Besides ALDH activity, Wnt protein has also been suggested to play an important regulatory role in tumour progression in breast cancer, further suggesting that the Wnt/β-catenin pathway could be a potential therapeutic target in overcoming drug-resistance in breast cancer [7]. This evidence concerns the gene LDHA and breast carcinoma.